# Vascular Healing After Deployment of Titanium-nitride-oxide-coated OPTIMAX™ Stent and PROMUS-ELEMENT™ Everolimus-Eluting Stent

> **NCT02280720** · PHASE4 · COMPLETED · sponsor: **The Hospital District of Satakunta** · enrollment: 40 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **PROCEDURE:** Stenting using Optimax™
- **PROCEDURE:** Stenting using PROMUS Element™ Plus

## Key facts

- **NCT ID:** NCT02280720
- **Lead sponsor:** The Hospital District of Satakunta
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-12
- **Final completion:** 2014-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2014-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02280720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02280720, "Vascular Healing After Deployment of Titanium-nitride-oxide-coated OPTIMAX™ Stent and PROMUS-ELEMENT™ Everolimus-Eluting Stent". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02280720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*